Question
Compare non-viral vs. viral vectors in gene therapy, their advantages/disadvantages, and applications in treating cystic fibrosis, hemophilia, cancer, and dermatological disorders.
Answer :
Word Count : 529
Gene therapy relies on efficient delivery systems to introduce therapeutic genes into target cells, broadly classified into viral and non-viral vectors. These two systems differ significantly in structure, efficiency, safety, and scope of application, influencing their suitability for treating genetic and acquired disorders such as cystic fibrosis, hemophilia, cancer, and dermatological diseases. Viral vectors are derived from genetically modified viruses such as adenovirus, adeno-associated virus (AAV), retrovirus, and lentivirus, in which pathogenic genes are removed and replaced with therapeutic DNA. Their major advantage lies in high transfection efficiency, __________ _______ _____ ______ _________ _______ _________ _____ _______ _________ ___ ____.
_________ ___ ________ ____ _______ __________ __________ ______ ___.
_________ ______ _____ ___ ______ _____ _________.
_____ _________ ______ ______ ________ __________ _______ _______ ____.
________ ____ __________ __________ ______ __________ _____ ___ ____.
_____ ___ ____ _____ __________.
___ ____ _____ _________ _________ ______ ____ __________ ________.
______ ________ ________ _________ __________ _____ ______ _____ ____ __________.
________ _____ ___ __________ _________ ___ ___ _______ ____ _______ _________ _______.
_______ _____ ______ __________ _________ _________ _______ _____ __________.
__________ __________ ____ __________ _______ ______ ___ ____ ___.
____ _______ __________ ________ ____ ___ ______ _____ _____ _______ ___ _____.
_______ _______ _____ ___ ____ _______ _____ __________ __________.
______ ________ _______ _______ __________ ___ _______ ________ ___ ______ ___.
______ ___ _________ _________ __________ _______ _______ _____ ______ _____ ___ ______.
_____ _____ __________ ___ _______ ___ _____ _________ __________ _______ ____.
______ _________ __________ _______ ______.
___ ___ _________ ___ ______ ______ _____ ______ ________ _____.
_______ _____ ________ __________ ___ _________ ________ _________ ___ ____.
____ ___ _____ ___ _______ _________ ____ _____.
_________ __________ ________ ________ _________ _____.
_________ ______ ______ ____ ____ _________ _____ ____ _____ ______ ____ __________.
_____ ___ _____ _______ ____ _______ _______ _________ _____ _________ ____ ____.
_____ __________ _______ ______ _______ ___ __________ _________ ______ ___.
_______ _______ _________ ____ ______ ______.
_____ _____ _____ _________ _________.
______ ______ __________ ___ ______ _______ ______ ___.
______ ___ __________ ___ _____ _____ ____ ______ ______ ____ ____.
________ __________ ___ ______ _____ ______ ______ ___ ____.
_______ _____ ____ ______ ___.
______ ___ __________ __________ _____ _____ _______.
___ ___ _____ ______ ___ __________ __________.
______ ______ ________ ____ ___ ___ _______.
____ __________ ______ __________ ____ __________ ___ _________ ________ _________ ________.
_______ _________ _______ _______ ________ ________ ___ _____ ______ _____.
______ ______ _________ _______ _________ ____ __________ _____ _______ ____ _____ _________.
____ __________ ___ ______ _________ ________.
_______ ___ _____ __________ ______ ___ _________ _____ __________ ___ ____ ___.
_____ ____ _____ ________ _____.
__________ _______ ________ _________ _____ ______.
_____ ____ _____ ________ ________ _________ ______ ____ _______ ______ ____.
_____ _______ ___ ___ _________ __________ ___ ________ _____ _______.
_______ ________ __________ __________ _______ _________ ___ _____ __________.
________ _____ _________ _____ _______ ______ _________.
_______ ________ ___ ______ ______ ________ ___ ________ ________.
_______ _________ _________ ___ _______ ________ ____ _____ ______ __________.
_________ _____ ____ _________ ______.
____ __________ ____ ______ ____ __________ _____ _________.
____ ___ ________ ____ ____.
_____ __________ ___ ______ __________ ____.
_____ __________ __________ ________ _______ __________.
Get Full Answer on WhatsApp
Gene therapy relies on efficient delivery systems to introduce therapeutic genes into target cells, broadly classified into viral and non-viral vectors. These two systems differ significantly in structure, efficiency, safety, and scope of application, influencing their suitability for treating genetic and acquired disorders such as cystic fibrosis, hemophilia, cancer, and dermatological diseases. Viral vectors are derived from genetically modified viruses such as adenovirus, adeno-associated virus (AAV), retrovirus, and lentivirus, in which pathogenic genes are removed and replaced with therapeutic DNA. Their major advantage lies in high transfection efficiency, __________ _______ _____ ______ _________ _______ _________ _____ _______ _________ ___ ____.
_________ ___ ________ ____ _______ __________ __________ ______ ___.
_________ ______ _____ ___ ______ _____ _________.
_____ _________ ______ ______ ________ __________ _______ _______ ____.
________ ____ __________ __________ ______ __________ _____ ___ ____.
_____ ___ ____ _____ __________.
___ ____ _____ _________ _________ ______ ____ __________ ________.
______ ________ ________ _________ __________ _____ ______ _____ ____ __________.
________ _____ ___ __________ _________ ___ ___ _______ ____ _______ _________ _______.
_______ _____ ______ __________ _________ _________ _______ _____ __________.
__________ __________ ____ __________ _______ ______ ___ ____ ___.
____ _______ __________ ________ ____ ___ ______ _____ _____ _______ ___ _____.
_______ _______ _____ ___ ____ _______ _____ __________ __________.
______ ________ _______ _______ __________ ___ _______ ________ ___ ______ ___.
______ ___ _________ _________ __________ _______ _______ _____ ______ _____ ___ ______.
_____ _____ __________ ___ _______ ___ _____ _________ __________ _______ ____.
______ _________ __________ _______ ______.
___ ___ _________ ___ ______ ______ _____ ______ ________ _____.
_______ _____ ________ __________ ___ _________ ________ _________ ___ ____.
____ ___ _____ ___ _______ _________ ____ _____.
_________ __________ ________ ________ _________ _____.
_________ ______ ______ ____ ____ _________ _____ ____ _____ ______ ____ __________.
_____ ___ _____ _______ ____ _______ _______ _________ _____ _________ ____ ____.
_____ __________ _______ ______ _______ ___ __________ _________ ______ ___.
_______ _______ _________ ____ ______ ______.
_____ _____ _____ _________ _________.
______ ______ __________ ___ ______ _______ ______ ___.
______ ___ __________ ___ _____ _____ ____ ______ ______ ____ ____.
________ __________ ___ ______ _____ ______ ______ ___ ____.
_______ _____ ____ ______ ___.
______ ___ __________ __________ _____ _____ _______.
___ ___ _____ ______ ___ __________ __________.
______ ______ ________ ____ ___ ___ _______.
____ __________ ______ __________ ____ __________ ___ _________ ________ _________ ________.
_______ _________ _______ _______ ________ ________ ___ _____ ______ _____.
______ ______ _________ _______ _________ ____ __________ _____ _______ ____ _____ _________.
____ __________ ___ ______ _________ ________.
_______ ___ _____ __________ ______ ___ _________ _____ __________ ___ ____ ___.
_____ ____ _____ ________ _____.
__________ _______ ________ _________ _____ ______.
_____ ____ _____ ________ ________ _________ ______ ____ _______ ______ ____.
_____ _______ ___ ___ _________ __________ ___ ________ _____ _______.
_______ ________ __________ __________ _______ _________ ___ _____ __________.
________ _____ _________ _____ _______ ______ _________.
_______ ________ ___ ______ ______ ________ ___ ________ ________.
_______ _________ _________ ___ _______ ________ ____ _____ ______ __________.
_________ _____ ____ _________ ______.
____ __________ ____ ______ ____ __________ _____ _________.
____ ___ ________ ____ ____.
_____ __________ ___ ______ __________ ____.
_____ __________ __________ ________ _______ __________.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★